3-Amino-2,2-dimethylpropionamide Market - Forecast(2023 - 2028)

3-Amino-2,2-Dimethylpropionamide Market Overview

3-Amino-2,2-Dimethylpropionamide Market size is expected to be valued at $872.3 million by the end of the year 2026 and is set to grow at a CAGR of 4.3% during the forecast period from 2021-2026. 3-Amino-2,2-dimethylpropionamide is extensively used as a primary building block in pharmaceuticals. It is also considered as an Active Pharmaceutical Ingredient (API). Thus, the increase in the production of pharmaceutical drugs across the globe is majorly contributing to the demand for 3-Amino-2,2-dimethylpropionamide. 3-Amino-2,2-dimethylpropionamide is also used as a reagent in the manufacture of Aliskiren, a direct renin inhibitor. Aliskiren is used in treating high blood pressure. The rising cases of high blood pressure among the working class and young people across the world is eventually giving rise to the demand for aliskiren, which is the main medicine used in curing high blood pressure. Therefore, the increase in the research and development activities in the pharmaceutical industry coupled with the increase in demand for medications and drugs that includes major composition of 3-Amino-2,2-dimethylpropionamide is hugely driving the 3-Amino-2,2-dimethylpropionamide market.

COVID-19 impact

Amid the Covid-19 pandemic, the 3-Amino-2,2-dimethylpropionamide market witnessed a slow growth despite other market crashing down. The covid-19 virus started causing various other health complications such as kidney failure, high blood pressure, cardiovascular diseases, hypertension and other complications. This gave rise to an increase in demand for the healthcare industry. Therefore, the demand for pharmaceutical medicines and drugs eventually increased, which in turn drove the demand for 3-Amino-2,2-dimethylpropionamide. 3-Amino-2,2-dimethylpropionamide market is further set to expand and grow during the year 2021.

Report Coverage

The report: “3-Amino-2,2-dimethylpropionamide Market – Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the3-Amino-2,2-dimethylpropionamide Industry.

Key Takeaways

• Asia-Pacific market held the largest share in the 3-Amino-2,2-dimethylpropionamide market owing to the rapid increase in the growth of pharmaceutical industry in countries like India, China and Japan.
• The increase in the production of aliskiren is highly driving the demand for 3-Amino-2,2-dimethylpropionamide market as it is used as a reagent in the production of aliskiren.
• The growing cases of diseases such as cardiovascular diseases, hypertension, high blood pressure and other similar ailments is one of the major factors contributing to the growth of the 3-Amino-2,2-dimethylpropionamide market.
• Amid the Covid-19 pandemic, the 3-Amino-2,2-dimethylpropionamide market witnessed a gradual growth in terms of production and demand owing to the increase in cases of diseases and ailments causes by the corona virus.

FIGURE: 3-Amino-2,2-Dimethylpropionamide Market Revenue, 2020-2026 (US$ Million)

For More Details on This Report - Request for Sample

3-Amino-2,2-Dimethylpropionamide Market Segment Analysis – By Purity

More than 99% segment held the largest share of 56% in the 3-Amino-2,2-dimethylpropionamide market in the year 2020. 3-Amino-2,2-dimethylpropionamide is majorly used in the pharmaceutical industry and therefore purity of 3-Amino-2,2-dimethylpropionamide plays a major role. Since 3-Amino-2,2-dimethylpropionamide is used for human consumption in the pharmaceutical industry, the purity of more than 99% held the largest segment. The increase in the use of 3-Amino-2,2-dimethylpropionamide in the pharma industry gave rise to the demand for more than 99% purity of 3-Amino-2,2-dimethylpropionamide as it is cleaner and less toxic for human consumption.

3-Amino-2,2-Dimethylpropionamide Market Segment Analysis – By Form

Liquid segment held the largest share of 48% in the 3-Amino-2,2-dimethylpropionamide market in the year 2020. 3-Amino-2,2-dimethylpropionamide is widely used in the production of pharmaceutical drugs and medicines. This is one of the main factors driving the demand for liquid segment in the 3-Amino-2,2-dimethylpropionamide market. The liquid 3-Amino-2,2-cimethylpropionamide comes in various compositions, which is widely used for various purposes in the pharmaceutical industry. It is also used in the production of various fine chemicals and reagents. Therefore, the increase in the research and development activities in the pharmaceutical industry is one of the main factors contributing to the growth of the 3-Amino-2,2-dimethylpropionamide market. 

3-Amino-2,2-Dimethylpropionamide Market Segment Analysis – By Grade 

Chemical grade segment held the largest share of 46% in the 3-Amino-2,2-dimethylpropionamide market in the year 2020. Chemical grade 3-Amino-2,2-dimethylpropionamide is used in the production of medical drug. These chemical grade 3-Amino-2,2-dimethylpropionamide is used for the purposes of laboratory findings and other research activities in the pharmaceutical industry. The increase in the growth and demand for the pharmaceutical industry across the globe is one of the major factors impacting the demand for chemical grade segment in the 3-Amino-2,2-dimethylpropionamid market.

3-Amino-2,2-Dimethylpropionamide Market Segment Analysis – By Application

Pharmaceutical industry held the largest share of 40% in the 3-Amino-2,2-dimethylpropionamide market in the year 2020. The increase in the growth of the pharmaceutical industry across the globe is one of the major contributors to the growth of the 3-Amino-2,2-dimethylpropionamide market. The increase in awareness among people regarding health in recent times is increasing the demand for the healthcare industry. Furthermore, the increase in the number of cases of diseases such as hypertension, anxiety and others are giving rise to the demand of medications that can calm the nerve and ease the blood pressure levels in the human body. This is giving rise to the demand for 3-Amino-2,2-dimethylpropionamide market. According to sources from European commission, the overall pharmaceutical companies in the region invested 15% of their total revenue in research and development of pharma industry during the year 2019. This was recorded as the highest amount of investment made compared to any other mainstream industry. Additionally, the Brazilian pharmaceutical industry grew by 11.2% during the year 2019. This is hugely contributing towards the growth of 3-Amino-2,2-dimethylpropionamide market. 

3-Amino-2,2-Dimethylpropionamide Market Segment Analysis – By Geography

Asia-Pacific region held the largest share of 43% in the 3-Amino-2,2-dimethylpropionamide market in the year 2020. The increasing demand for pharmaceutical drugs and medicines to curb various diseases such as high blood pressure, hypertension, anxiety and others which has been in the rise among the young population is one of the major factors driving the 3-Amino-2,2-dimethylpropionamide market. For instance, according to India Brand Equity Foundation (IBEF), the pharmaceutical industry in India is estimated to be around US$41 billion by the end of 2021. Furthermore, the investments in the pharmaceutical industry in India stood at USS17.5 billion in the year 2020 and the Indian government further announced an incentive scheme in February 2021 which will attract investments of US$2.07 billion into the sector. This will majorly impact the 3-Amino-2,2-Dimethylpropionamide market in the region. According to the latest report published by European Federation of Pharmaceutical Industries and Associations in the year 2020, the pharmaceutical industry of China and India grew by 6.9% and 11.1% respectively during the time period of 2014-2019. Furthermore, according to International Trade Administration, the production in pharmaceuticals industry in Japan increased by 35.2% to US$84.6 million during the year 2019 from US$62.57 million in the year 2018. This is driving the Asia-Pacific region of the 3-Amino-2,2-dimethylpropionamide market.

3-Amino-2,2-Dimethylpropionamide Market Drivers

Rapid growth in the pharmaceutical industry

The increase in the growth of the pharmaceutical industry across the globe is one of the main factors which is highly driving the demand for 3-Amino-2,2-dimethylpropionamide market across the globe. 3-Amino-2,2-dimethylpropionamide is extensively used as a primary building block of many medicines and drugs. 3-Amino-2,2-dimethylpropionamide is also an Active Pharmaceutical Ingredient (API), which is used as a base for various medications. This is giving rise to the demand for 3-Amino-2,2-dimethylpropionamide in the pharmaceutical industry. For instance, according to the latest report published by European Federation of Pharmaceutical Industries and Associations in the year 2020, the pharmaceutical industry in the United States grew by 6.1% and the pharmaceutical industry of the European Nation grew by 5.4% during the year 2019. This is one of the major factors driving the growth and demand of the 3-Amino-2,2-dimethylpropionamide market in the pharmaceutical industry. 

The Increasing awareness about hypertension and high blood pressure among the working class and young people

There has been an increase in the case of hypertension and high blood pressure levels among the working class and young people across the world. It has been linked with the increasing pressure of work load and peer pressure among the young population. In the recent days, there has been an increase in awareness among the young people to curb the condition of high-pressure levels and hypertension to curb long term health complications. This has been driving the demand for medicines and drugs to cure such ailments which in turn is driving the growth and demand of the 3-Amino-2,2-dimethylpropionamide market. According to World Health Organisation, one of the global targets is to reduce the prevalence of hypertension by 25% by 2025. This will further increase the demand for medicines that cures hypertension and high-pressure levels, which will eventually increase the demand for the 3-Amino-2,2-dimethylpropionamide market.

3-Amino-2,2-Dimethylpropionamide Market Challenges

Government rules and regulations restricting the growth of the 3-Amino-2,2-dimethylpropionamide market

The are various guidelines issued by government and other regulatory bodies regarding the use of chemical substances. These guidelines require the reporting and compilation of various legal standards and paperwork. Certain type of toxic substances has been prohibited from large use, owing to their volatile and dangerous nature. 3-Amino-2,2-dimethylpropionamide is also a dangerous substance, and comes under the scrutiny of government. According to the United States Environmental Protection Agency, certain toxic substances, including 3-Amino-2,2-dimethylpropionamide is listed as a toxic substance under The Toxic Substances Control Act of 1976. These regulations and standards are limiting the growth of the 3-Amino-2,2-dimethylpropionamide market.

3-Amino-2,2-Dimethylpropionamide Market Industry Outlook

Investments, collaboration partnerships, acquisitions and mergers, production expansion and facility expansion are some of the key strategies adopted by players in the 3-Amino-2,2-Dimethylpropionamide Market. Major players in the 3-Amino-2,2-Dimethylpropionamide Market include:

1. Toronto Research Chemicals Inc.
2. Hangzhou Coben Pharmaceutical Co Ltd.
3. BASF AG
4. Advanced ChemBlocks Inc.
5. Yangzhou Princechem Co Ltd.
6. Clearsynth Canada INC
7. Zhejiang Tianyu Pharmaceutical Co. Ltd.
8. Dishman USA Inc.
9. Matrix Scientific
10. Jinan Finer Chemical Co. Ltd.
11. LUNA Chemicals Co. Ltd.
12. Ark Pharm Inc.
13. Shanghai Yuanye Bio-Technology Co. Ltd.
14. BrightGene Bio-medical Technology Co. Ltd.
15. Nanjing Ange Pharmaceutical Co. Ltd. among others.

Relevant Reports

For more Chemicals and Materials Market reports, please click here